Allergan tries to escape Restasis IPRs
brianajackson / iStockphoto.com
The US Court of Appeals for the Federal Circuit has ordered the Patent and Trial Appeal Board (PTAB) to halt its review of patents covering a dry eye medication while the court considers arguments that tribal immunity protects the patents from board proceedings.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Patent and Trial Appeal Board, Allergan, Restasis inter partes review, Saint Regis Mohawk Tribe immunity